Breakthrough for AlzeCure in the development of drugs for nerve pain

AlzeCure Pharma shows positive results from its clinical study with a new non-opioid drug candidate developed against peripheral neuropathic pain.

New data from AlzeCure’s phase IIa study show that the drug candidate ACD440 has a significant analgesic effect on pain induced by cold and heat.

– The medical need in this area is immense, not least to find alternatives to opioids. Neuropathic pain is the single largest market segment in pain management, generating over $11 billion in annual revenues. Up to 80 percent of all patients do not get a satisfactory effect with their current treatments, said AlzeCure Pharma’s CEO Martin Jönsson.

AlzeCure is among a handful of companies in the world that develop drugs that target the TRPV1 receptor, whose discovery was awarded the 2021 Nobel Prize in Medicine. The goal is to help people who suffer from nerve pain. In many cases today, there is no other effective treatment available than opioids, which both numb the whole body and can lead to addiction and substance abuse.

More on the new study.

Published On: 2 June 2023
  • Good news for Flemingsberg commuters

    Earlier this week, Mitt i Stockholm reported the joyful news that they will be increasing the number of departures on the Södertälje commuter train during rush hours starting from Monday, October 30th. This means that the trains will run eight times per hour.

  • Circio

    "We are in Flemingsberg due to the availability of competent workforce in this sector and its infrastructure. Additionally, we were able to find a lab right next to the Karolinska Institutet, which also has excellent infrastructure."

  • TAKE YOUR IDEA TO THE NEXT LEVEL: Flemingsberg Science Award IDEA 2023 is now open for registration

    It’s finally time for the annual competition, Flemingsberg Science Award. [...]

  • Doors open for creativity and culture

    Innovation Station is the new co-working space in Flemingsberg that [...]

  • Navigating the life science ecosystem

    Have you considered what support and opportunities are available to [...]